Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Self-care in Europe

This article was originally published in The Tan Sheet

Executive Summary

Self-managing health care is becoming increasingly acceptable in Europe, Hubertus Cranz, PhD, director general of the Association of the European Self-Medication Industry (AESGP) said during CHPA's Regulatory & Scientific Conference in Washington, D.C. May 2. "Ten, 15 years ago it would have been impossible to even talk about a patient self-managing health care," he explained, describing the European setting as "much more restrictive" than that in the U.S. or UK. Progress has since been made, Cranz said, pointing out that from 2001 to 2002 the Standing Committee of European Doctors participated in AESGP's study on new indications for self-medication. In 2006, the AESGP was involved in a joint project with the World Medical Association entitled, "From Patient to Self-Health Manager." Cranz credited the UK for setting the example, explaining that the "UK government policy is to encourage self-care"...

You may also be interested in...



David Now Goliath? Made In China PD-1s Sought After By Multinationals

From relatively little-known to high-flying, hotly pursued targets by global pharma players, Chinese domestically developed immuno-oncology drugs are ascending in both value and attractiveness, both inside China and far beyond.

How Heads Of Indian Firms Rallied To Sustain Global Supplies Amid COVID-19

The leadership of top Indian firms recounted at the IPA Forum how they got together on a joint 45-minute call daily in the early phase of the pandemic to collaborate and ensure uninterrupted supplies of medicines both in India and globally. The executives also shared views on telemedicine and digitalization trends at the event.

QUOTED. 3 March 2021. Greg Dadika.

Medtech Insight spoke to attorney Greg Dadika about mass tort litigation, including industry trends, how to find the right law firm, and when it’s the right time to settle a suit. See what Dadika, an attorney at the law firm Greenberg Traurig LLP, said about it here.

Topics

UsernamePublicRestriction

Register

LL1129949

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel